GENB — GENERATE BIOMEDICINES INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 92 家机构在其最新 13F 申报中持有 GENB(GENERATE BIOMEDICINES INC),合计申报市值 $1.79B,对应 108.21M 股。按股数计算较上季度增持 1.7%(+1.73M 股),申报市值环比上升 37.6%。持仓集中度较高:前五大持有人占申报市值的 75.1%,前十大的集中度为 84.1%。
与上一季度相比,44 家新建仓位、26 家加仓、11 家减仓、15 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
GENERATE BIOMEDICINES INC(GENB)的主要机构持有人包括 Flagship Pioneering, LLC、Fidelity Management & Research (FMR)、Capital World Investors,按 13F 申报市值在本页 131 家持有人中排名居前。
GENB 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 GENB 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 GENB 的名单——每位投资人按其自身最近一个季度展示。
| 投资人 | 季度 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|---|
|
|
Q3 2026 | 1.96M | $29.51M | 0.17% | 增持 |
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 69 | 27.72M | $417.54M | +26.6% |
| Q2 2026 | 92 | 108.21M | $1.79B | +1.7% |
| Q1 2026 | 63 | 100.53M | $1.23B | — |
表内 3 个季度中,机构持股合计减少 72%(Q1 2026 → Q3 2026)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.19M | $107.94M | 0.01% | 增持 | |
| 4.20M | $63.11M | 0.01% | 持有 | |
| 2.65M | $40.94M | 0.01% | 增持 | |
| 2.24M | $33.58M | 0.00% | 增持 | |
| 1.96M | $29.51M | 0.17% | 增持 | |
| 1.83M | $27.49M | 0.00% | 增持 | |
| 1.77M | $26.63M | 0.39% | 新进 | |
| 824.68K | $12.39M | 2.41% | 持有 | |
| 736.10K | $11.06M | 0.26% | 持有 | |
| 729.08K | $10.95M | 0.00% | 减持 | |
| 546.34K | $8.21M | 0.00% | 新进 | |
| 522.41K | $7.85M | 0.00% | 增持 | |
| 204.18K | $3.07M | 0.00% | 增持 | |
| 180.00K | $2.78M | 0.00% | 增持 | |
| 170.04K | $2.55M | 0.01% | 增持 | |
| 169.76K | $2.55M | 0.00% | 增持 | |
| 144.76K | $2.17M | 0.42% | 新进 | |
| 139.42K | $2.09M | 0.01% | 新进 | |
| 126.95K | $1.91M | 0.00% | 减持 | |
| 120.30K | $1.81M | 0.01% | 增持 | |
| 118.47K | $1.78M | 0.00% | 增持 | |
| 115.99K | $1.74M | 0.00% | 增持 | |
| 100.00K | $1.50M | 0.07% | 减持 | |
| 85.28K | $1.28M | 0.00% | 增持 | |
| 84.96K | $1.28M | 0.08% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 62.67M | $1.06B | 68.66% | 持有 | |
| 5.22M | $88.09M | 0.00% | 增持 | |
| 4.22M | $71.12M | 0.01% | 增持 | |
| 4.22M | $71.12M | 0.01% | 增持 | |
| 3.28M | $55.40M | 2.18% | 减持 | |
| 2.16M | $36.38M | 0.00% | 增持 | |
| 2.09M | $35.34M | 0.00% | 新进 | |
| 1.94M | $32.80M | 2.98% | 持有 | |
| 1.72M | $29.05M | 17.09% | 持有 | |
| 1.66M | $28.00M | 0.00% | 新进 | |
| 1.42M | $24.02M | 0.13% | 持有 | |
| 1.41M | $23.84M | 0.00% | 减持 | |
| 1.33M | $22.50M | 0.34% | 新进 | |
| 1.28M | $21.67M | 0.14% | 增持 | |
| 1.13M | $19.11M | 0.00% | 增持 | |
| 1.11M | $18.74M | 0.91% | 持有 | |
| 1.11M | $18.74M | 0.44% | 持有 | |
| 833.33K | $14.06M | 0.02% | 持有 | |
| 824.68K | $13.91M | 2.37% | 增持 | |
| 736.10K | $12.42M | 0.25% | 持有 | |
| 735.00K | $12.40M | 0.00% | 新进 | |
| 735.00K | $12.40M | 0.00% | 增持 | |
| 400.00K | $6.75M | 0.33% | 增持 | |
| 377.99K | $6.38M | 0.00% | 增持 | |
| 326.27K | $5.50M | 0.00% | 减持 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 62.67M | $783.41M | 67.44% | 新进 | |
| 4.22M | $52.72M | 0.00% | 新进 | |
| 4.00M | $50.05M | 0.01% | 新进 | |
| 4.00M | $50.05M | 0.01% | 新进 | |
| 3.59M | $44.91M | 1.70% | 新进 | |
| 2.95M | $33.92M | 0.00% | 新进 | |
| 2.11M | $26.37M | 0.00% | 新进 | |
| 1.94M | $24.31M | 3.59% | 新进 | |
| 1.72M | $21.53M | 21.33% | 新进 | |
| 1.42M | $17.80M | 0.11% | 新进 | |
| 1.11M | $13.89M | 0.77% | 新进 | |
| 1.11M | $13.89M | 0.77% | 新进 | |
| 833.33K | $10.42M | 0.06% | 新进 | |
| 736.10K | $9.20M | 0.26% | 新进 | |
| 591.80K | $7.40M | 2.03% | 新进 | |
| 500.00K | $6.25M | 0.02% | 新进 | |
| 498.41K | $6.23M | 0.05% | 新进 | |
| 376.89K | $4.71M | 0.00% | 新进 | |
| 376.89K | $4.71M | 0.01% | 新进 | |
| 356.70K | $4.46M | 0.00% | 新进 | |
| 350.00K | $4.38M | 0.23% | 新进 | |
| 337.30K | $4.22M | 0.00% | 新进 | |
| 311.99K | $3.90M | 0.04% | 新进 | |
| 266.81K | $3.34M | 0.18% | 新进 | |
| 185.00K | $2.31M | 0.38% | 新进 |
新建仓(Q2 2026)
- Norges Bank Investment Management 2.09M 股 · $35.34M
- BlackRock Inc 1.66M 股 · $28.00M
- Deep Track Capital, LP 1.33M 股 · $22.50M
- GEODE CAPITAL MANAGEMENT, LLC 735.00K 股 · $12.40M
- Charles Schwab Investment Management 224.60K 股 · $3.79M
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 224.60K 股 · $3.79M
- Sixth Street Partners Management Company, L.P. 224.60K 股 · $3.79M
- Northern Trust Corp 197.54K 股 · $3.33M
- VANGUARD PORTFOLIO MANAGEMENT LLC 167.28K 股 · $2.82M
- ALPS ADVISORS INC 129.41K 股 · $2.18M
- BNY Mellon 57.33K 股 · $967.09K
- Nuveen, LLC 44.47K 股 · $750.21K
完全清仓(较上季)
- Alyeska Investment Group, L.P. 卖出 500.00K 股 · $6.25M
- ExodusPoint Capital Management, LP 卖出 311.99K 股 · $3.90M
- JANE STREET GROUP, LLC 卖出 123.37K 股 · $1.54M
- SILVERARC CAPITAL MANAGEMENT, LLC 卖出 100.00K 股 · $1.25M
- D. E. Shaw & Co 卖出 95.00K 股 · $1.19M
- D. E. Shaw & Co., Inc. 卖出 95.00K 股 · $1.19M
- Balyasny Asset Management 卖出 79.49K 股 · $993.61K
- HRT FINANCIAL LP 卖出 58.76K 股 · $734.00K
- Qube Research & Technologies Ltd 卖出 50.22K 股 · $627.76K
- TUDOR INVESTMENT CORP ET AL 卖出 23.83K 股 · $297.91K
- Y-Intercept (Hong Kong) Ltd 卖出 18.36K 股 · $229.53K
- Hudson Bay Capital Management LP 卖出 16.68K 股 · $208.47K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Fidelity Management & Research (FMR) | 7.19M | 5.22M | 4.22M |
| Capital World Investors | 4.20M | 4.22M | 4.00M |
| JPMorgan Chase & Co | 2.65M | 1.41M | 2.95M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.24M | 1.13M | 131.32K |
| ARK Invest | 1.96M | 1.28M | 498.41K |
| BlackRock Inc | 1.83M | 1.66M | — |
| BANQUE PICTET & CIE SA | 1.77M | — | — |
| Davern Capital Partners, LP | 824.68K | 824.68K | 591.80K |
| Siren, L.L.C. | 736.10K | 736.10K | 736.10K |
| Geode Capital Management | 729.08K | 735.00K | 118.24K |
| STATE STREET CORP | 546.34K | — | — |
| Morgan Stanley | 522.41K | 377.99K | 337.30K |
| VANGUARD FIDUCIARY TRUST CO | 204.18K | 175.36K | 17.46K |
| TD ASSET MANAGEMENT INC | 180.00K | 50.75K | 42.87K |
| ALPS ADVISORS INC | 170.04K | 129.41K | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 169.76K | 167.28K | — |
| Prosight Management, LP | 144.76K | — | — |
| Savant Capital, LLC | 139.42K | — | — |
| UBS Group AG | 126.95K | 326.27K | 356.70K |
| Quadrature Capital Ltd | 120.30K | 31.51K | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold GENB?
As of 2026-Q2, 92 institutional funds reported holding GENB (GENERATE BIOMEDICINES INC) in SEC 13F filings, with a combined reported value of $1.79B.
How many shares of GENB do institutions own?
13F filers reported 108.21M shares of GENB, worth $1.79B in aggregate at the end of 2026-Q2.
Is institutional ownership of GENB rising or falling?
Share counts moved +1.7% versus the prior quarter — accumulation.
Who are the top institutional holders of GENB?
The largest 13F holders are Flagship Pioneering, LLC, Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, BRAIDWELL LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of GENERATE BIOMEDICINES INC?
The major shareholders of GENERATE BIOMEDICINES INC (GENB) by reported 13F value are Flagship Pioneering, LLC, Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, BRAIDWELL LP, among 131 institutional holders.
Which legendary investors own GENB?
1 of the legendary investors tracked on HoldingsHub report GENB (GENERATE BIOMEDICINES INC) in their latest 13F filings, led by ARK Invest. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on GENB?
1 tracked superinvestors hold GENB simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.